Chemoinformaics analysis of (2e,6e,8e)-n-(2-Methylpropyl)-2,6,8-decatrienamide
| Molecular Weight | 221.344 | nRot | 7 |
| Heavy Atom Molecular Weight | 198.16 | nRig | 4 |
| Exact Molecular Weight | 221.178 | nRing | 0 |
| Solubility: LogS | -2.379 | nHRing | 0 |
| Solubility: LogP | 2.15 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 40.6182 |
| nHD | 1 | BPOL | 24.5118 |
| QED | 0.519 |
| Synth | 2.927 |
| Natural Product Likeliness | 1.09 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.007 |
| CACO-2 | -4.361 |
| MDCK | 0.0000836 |
| BBB | 0.722 |
| PPB | 0.864519 |
| VDSS | 1.092 |
| FU | 0.160754 |
| CYP1A2-inh | 0.848 |
| CYP1A2-sub | 0.406 |
| CYP2c19-inh | 0.829 |
| CYP2c19-sub | 0.728 |
| CYP2c9-inh | 0.323 |
| CYP2c9-sub | 0.979 |
| CYP2d6-inh | 0.395 |
| CYP2d6-sub | 0.898 |
| CYP3a4-inh | 0.303 |
| CYP3a4-sub | 0.179 |
| CL | 8.659 |
| T12 | 0.778 |
| hERG | 0.035 |
| Ames | 0.426 |
| ROA | 0.02 |
| SkinSen | 0.927 |
| Carcinogencity | 0.156 |
| EI | 0.896 |
| Respiratory | 0.307 |
| NR-Aromatase | 0.003 |
| Antiviral | Yes |
| Prediction | 0.752427 |